AHY 0.72% $1.41 asaleo care limited

Column 1| Column 2| Column 3| Column 4| Column 5| Column 6|...

  1. 7,719 Posts.
    lightbulb Created with Sketch. 161
    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 Column 9
    1 AHY Receipts rec excl gst net receipts net rec excl gst listing expenses adj net receipts (excl GST)   Revenue
    2 2012 691.6 628.7 124.5 113.2   113.2   622
    3 2013 687.2 624.7 124.5 113.2   113.2   624.3
    4 2014 689.4 626.7 63.0 57.3 30.5 87.8   629.9
    5 2015 693.7 630.6 139.4 126.7   126.7   622.2
    6 2016 - guess - by averaging 2014 and 2015           107.3    
    The numbers above use details from the last few years financials. There may have been a Zag Zig, where net cashflow was diverted from FY14 to FY15. I may also be nuts - so DYOR.

    Equating EBITDA with net receipts excl GST => Knock $19m off their U EBITDA 15 and you get $126m
    adj NPBT => 87.7
    adj NPAT 15 @ 30% tax => 61.4m.

    Unpat target based on FY 16 guidance is about 64.7m approx. So my back of envelope calcs very roughly add up  - wish I had a bit more time.

    This is not a growth company at all IMO. It is a shrinking company most likely with no top line growth, and little ability to extract costs out of the business. If I am right this has something in common with SPO, DSH etc.

    I have had very little time to focus on this - so may be missing something very big here - so DYOR and don't rely on my back of the envelope calcs.
    Last edited by CaptainBarnacles: 22/07/16
 
watchlist Created with Sketch. Add AHY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.